Press release
Mucolipidosis II Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 | Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Indus
As per the report, the mucolipidosis II market size has grown steadily in recent years. It will grow from $12.61 billion in 2023 to $13.13 billion in 2024 at a compound annual growth rate (CAGR) of 4.1%. The mucolipidosis II market size is expected to see steady growth in the next few years. It will grow to $15.52 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%.Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16746&type=smp
Gene Therapy Advancements Propel Growth of the Mucolipidosis II Market
The rise in gene therapy is expected to propel the growth of the mucolipidosis II market going forward. Gene therapy is an advanced medical technique that aims to treat or prevent genetic disorders by correcting faulty genes or introducing new genes into a patient's cells through methods such as gene addition, gene editing, gene silencing, and gene regulation, gene therapy. Gene therapy offers a promising approach to treating ML II by addressing the root genetic cause of the disorder. The approach involves introducing a functional copy of the gene into the patient's cells to restore the production of the enzyme. For instance, in April 2024, according to the American Society of Gene & Cell Therapy, a US-based organization for gene and cell therapy, the number of gene therapies in phase III clinical trials increased by 10% in the third quarter of 2023, marking the first quarterly rise since the third quarter of 2022. Therefore, the rise in gene therapy will drive the market for mucolipidosis II.
Impact of Increased Research and Development Activities on the Mucolipidosis II Market
The rise in research and development activities is expected to propel the growth of the mucolipidosis II market going forward. Research and development (R&D) activities involve systematic investigation and experimentation to discover new knowledge or create new products, processes, or services. Research and development (R&D) activities are increasing due to the growing need for innovation and competitive advantage in various industries. Research and development activities are crucial for advancing treatments for Mucolipidosis II by improving the understanding of the disease, developing gene therapies to address underlying genetic mutations, enhancing delivery methods, and conducting preclinical and clinical trials. For instance, in April 2024, according to the Office for National Statistics, a UK-based government department for collecting and publishing statistics, in 2022, the UK government's spending on research and development increased to £15.5 ($19.67) billion from £14.0 ($17.77) billion in 2021, marking a 10.5% rise. Therefore, the rise in research and development activities will drive the market for mucolipidosis II.
Advances in Gene Therapy for Mucolipidosis II
Major companies operating in the mucolipidosis II market are developing gene therapies to address the underlying genetic mutations causing the disease. Gene therapies aim to deliver functional copies of the defective genes into patients' cells, thereby correcting the metabolic dysfunctions characteristic of ML II. For instance, in February 2021, M6P Therapeutics, a US-based biotechnology company, received orphan drug designation for M002 S1S3 PTase AAV gene therapy for mucolipidosis. It leverages M6P Therapeutics' S1S3 bicistronic platform to deliver a truncated phosphotransferase (PTase) enzyme via an AAV-9 vector. In the ML-II mouse model, M002 restores phosphorylation of soluble lysosomal enzymes within transduced cells within 3 weeks after dosing.
The mucolipidosis ii market covered in this report is segmented -
1) By Treatment: Antibiotics, Physical Therapy, Hip Replacement, Experimental Therapies, Other Treatments
2) By Mode Of Administration: Injectable, Oral, Other Modes Of Administration
3) By Symptoms: Deafness, Lack Of Muscle Tone (Hypotonia), Abnormal Spine Curvature, Changing Proportion of Mental Retardation, Low Growth Of Gross And Fine Motor Skills, Other Symptoms
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16746&type=discount
Major companies operating in the mucolipidosis ii market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Jazz Pharmaceuticals, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Alembic Pharmaceuticals, Ultragenyx Pharmaceutical Inc., Regenxbio Inc., Denali Therapeutics Inc., Mylan N.V., Intellia Therapeutics Inc., Avrobio Inc., Orchard Therapeutics plc, Eloxx Pharmaceuticals Inc., Lysogene S.A., Sio Gene Therapies, Homology Medicines Inc., BSN medical GmbH, Abeona Therapeutics Inc
Contents of the report:
1. Executive Summary
2. Mucolipidosis II Market Report Structure
3. Mucolipidosis II Market Trends And Strategies
4. Mucolipidosis II Market - Macro Economic Scenario
5. Mucolipidosis II Market Size And Growth
…..
27. Mucolipidosis II Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/mucolipidosis-ii-global-market-report
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mucolipidosis II Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 | Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Indus here
News-ID: 3629875 • Views: …
More Releases from the business research company
![Walk-In Refrigerator Market: Size, Share, Growth, Analysis, Key Players, Revenue](https://cdn.open-pr.com/L/9/L910436061_g.jpg)
Walk-In Refrigerator Market: Size, Share, Growth, Analysis, Key Players, Revenue
The new report published by The Business Research Company, titled Walk-In Refrigerator Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the walk-in refrigerator market size has grown strongly in recent years. It will grow from $11.34 billion in 2023…
![Three Dimensional (3D) Integrated Circuits (IC) Market: Trends, Challenges, and Future Growth](https://cdn.open-pr.com/L/9/L910223030_g.jpg)
Three Dimensional (3D) Integrated Circuits (IC) Market: Trends, Challenges, and …
The new report published by The Business Research Company, titled Three Dimensional (3D) Integrated Circuits (IC) Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the three dimensional (3D) integrated circuit (IC) market size has grown rapidly in recent years.…
![Smart Pet Locator And Motion Detector Market: Size, Share, Growth, Analysis, Key Players, Revenue](https://cdn.open-pr.com/L/9/L910714892_g.jpg)
Smart Pet Locator And Motion Detector Market: Size, Share, Growth, Analysis, Key …
The new report published by The Business Research Company, titled Smart Pet Locator And Motion Detector Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the smart pet locator and motion detector market size has grown strongly in recent years.…
![Robotic Wheelchairs Market: Size, Share, Growth, Analysis, Key Players, Revenue](https://cdn.open-pr.com/L/9/L910736053_g.jpg)
Robotic Wheelchairs Market: Size, Share, Growth, Analysis, Key Players, Revenue
The new report published by The Business Research Company, titled Robotic Wheelchairs Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the robotic wheelchairs market size has grown strongly in recent years. It will grow from $11.3 billion in 2023…
More Releases for Mucolipidosis
Teleradiology Market: Demand Analysis, Industry Size, Share, Growth Factor, Key …
The winning Teleradiology market report assists clients accomplish unparalleled competitive advantage in their respective domains. It is also supportive in gaining global perspective on the development of the Teleradiology market. Operating in a fast-paced business and technological environment can prove to be quite challenging and may involve a high degree of risk. Choosing an excellent market research report is always better to mitigate the risk. A team of skilled analysts…
Sialidosis Market 2021 to Perceive Biggest Trend and Opportunity by 2028
A new market study is released on Sialidosis Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. Research report has been organized with the most advanced insight and analysis to give maximum benefits to the industry. The report can be used by both established and new players in the industry for complete understanding of the market. …
Lysosomal Storage Disorder (LSD) Therapeutics Pipeline to Witness Remarkable Gro …
LSD refers to a group of genetically inherited disorders, which are characterized by enzyme deficiencies. It results in accumulation of toxic chemical substances in the body’s cells. This group of disorders consists of approximately 50 diseases, including Metachromatic leukodystrophy; Mucolipidosis types I, II/III, and IV; Mucopolysaccharide storage disease; Gaucher disease; Niemann-Pick disease type C (NPC); Schindler disease types I and II; Tay Sachs disease; Pompe disease; and Sandhoff disease. These…